JENNA BEREZANSKY: Open Payments
NPI 1447905823 · LUMBERTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,235 in 68 payments from 13 companies in 2025. Trend: 2023 $926 · 2024 $1,098 · 2025 $1,235
Food & beverage: $1,235
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $253 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 10 | $186 |
| Ardelyx, Inc. | 4 | $174 |
| Phathom Pharmaceuticals, Inc. | 11 | $130 |
| Lilly USA, LLC | 5 | $93 |
| Janssen Biotech, Inc. | 4 | $76 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $75 |
| Madrigal Pharmaceuticals | 4 | $73 |
| Celltrion USA Inc. | 4 | $70 |
| Regeneron Healthcare Solutions, Inc. | 2 | $40 |
Products named: XIFAXAN, IBSRELA, VOQUEZNA, OMVOH, SKYRIZI, TREMFYA, REZDIFFRA, VEGZELMA.
Industry payments across NJ — which companies pay providers there.
